1. Home
  2. COOK vs TARA Comparison

COOK vs TARA Comparison

Compare COOK & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Traeger Inc.

COOK

Traeger Inc.

N/A

Current Price

$51.74

Market Cap

144.4M

ML Signal

N/A

Logo Protara Therapeutics Inc.

TARA

Protara Therapeutics Inc.

N/A

Current Price

$2.76

Market Cap

159.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
COOK
TARA
Founded
1985
N/A
Country
United States
United States
Employees
433
N/A
Industry
Wholesale Distributors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
144.4M
159.6M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
COOK
TARA
Price
$51.74
$2.76
Analyst Decision
Hold
Strong Buy
Analyst Count
7
8
Target Price
★ $62.33
$25.71
AVG Volume (30 Days)
21.2K
★ 1.3M
Earning Date
11-04-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 38.25
EPS
N/A
★ N/A
Revenue
★ $559,520,000.00
$2,948,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.24
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.48
$2.51
52 Week High
$86.59
$7.82

Technical Indicators

Market Signals
Indicator
COOK
TARA
Relative Strength Index (RSI) 51.21 28.82
Support Level $47.08 N/A
Resistance Level $52.05 $4.13
Average True Range (ATR) 2.86 0.21
MACD 0.80 -0.05
Stochastic Oscillator 70.20 16.71

Price Performance

Historical Comparison
COOK
TARA

About COOK Traeger Inc.

Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.

About TARA Protara Therapeutics Inc.

Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.

Share on Social Networks: